Otsuka Precision Health and Amalgam have unveiled Elevmi, an intelligent digital application designed to enhance the Alzheimer's disease caregiving experience. 🔗eu1.hubs.ly/H0d3bhk0

Researchers at UCLA have developed SLIViT, an AI system that can analyze complex medical images like MRI and 3D scans with unprecedented precision levels. But what does this mean for patients? #SLIViT #MedicalImaging #AI eu1.hubs.ly/H0d5l6n0

Researchers have developed a 'mixture of experts' model to detect artifacts in microscope slides, overcoming a key limitation of current AI methods. Get the details on the study here. 📊 #Pathology #AI #CancerCare eu1.hubs.ly/H0d6SHB0

Two recent studies show that AI-driven tools like DALL-E 3 depict pharmacists and medical students inaccurately, failing to represent the gender and ethnic diversity within these professions. #AI #DiversityInMedicine #AIBias #DALLE eu1.hubs.ly/H0d8CtQ0

Clinical trials show that Evaxion’s AI-Immunology platform can predict patient immune responses with high accuracy. EVX-01 has now entered Phase 2 trials, showing great promise for personalized cancer vaccines. #AI #Immunotherapy #CancerResearch eu1.hubs.ly/H0dcZFB0

The intersection of AI and Alzheimer’s care: Lenovo demos Liv, a photorealistic avatar offering advice and emotional engagement to help dementia patients. #HealthcareInnovation #AI #Dementia eu1.hubs.ly/H0dd2nC0

Antiverse has raised £3.5M in seed funding to grow its AI-powered antibody design platform, accelerating drug discovery for complex targets like GPCRs. Learn more about their mission to make challenging targets druggable. #Biotech #AI #AntibodyDiscovery eu1.hubs.ly/H0dcTHx0

AI Chatbots May Provide Harmful Drug Information 🚨 A recent study published in BMJ reveals that AI chatbots often include dangerous inaccuracies in medication advice. Of a subgroup of 20 answers, 66% were considered potentially dangerous, and 22% could even lead to severe

🚀 Exciting news from Google! They are developing a machine learning model to enhance fetal health prediction using cardiotocography data. Their innovative approach aims to help clinicians assess fetal well-being more accurately, potentially improving outcomes. Real the full

New study reveals that ambient AI tools could revolutionize clinical consultations! By improving documentation quality and reducing consultation times, AI has the potential to ease workloads and enhance patient care. Read the full article here: #AIinHealthcare

Inizio Medical has appointed Patrick Giordani as Senior VP, AI Solutions Architect, reinforcing its commitment to AI innovation in healthcare. Giordani brings over 20 years of experience in data science and AI, focusing on developing solutions that enhance content delivery and

CalmWave's AI-powered platform has cut non-actionable ICU alarms by 58% in a trial with Wellstar Health System, helping reduce alarm fatigue—a major cause of burnout and cognitive overload for healthcare staff. fmai-hub.com/ai-cuts-icu-al…

Thrilling developments in genetic medicine! Basecamp Research's recent Series B funding, led by David R. Liu, aims to harness AI for transformative advancements in genetic therapies. This innovative approach could revolutionize how we treat genetic diseases. 🌟 Dive into the

Built by radiologists, for radiologists, Hexarad 's ReportRad and OptiRad are holistic software solutions that tackle the imbalance between radiology scan demand and analysis capacity. Offering industry-leading turnaround times, ReportRad plugs into existing workflows to

Does regulation stifle innovation in healthcare? Join us for an illuminating conversation with Dr @DrHughHarvey , Founder of @HardianHealth and a leading expert in AI healthcare regulation. From his journey as a radiologist to becoming a key figure in healthcare tech

Can AI help us reimagine healthcare in a way that serves humanity first? Or are we sleepwalking into a future where efficiency trumps empathy?🤔 Find out in this enthralling Expert Insight with Liam Cahill (who refuses to allow us to call him one) as he delivers an unflinching

🚨 In a (genuine) breakthrough for drug discovery, Insilico Medicine (Alex Zhavoronkov, PhD (aka Aleksandrs Zavoronkovs)) and Acceleration Consortium at the University of Toronto (Igor Stagljar & (Igor Stagljar & Alán Aspuru-Guzik)) have used a hybrid of AI (classical) and quantum computing to unlock a previously

Insilico Medicine(Insilico Medicine) is off to a strong start in 2025. Our latest article draws together recent developments contributing to this momentum, including: 🚨 Yesterdays announcement of ISM6331 (for mesothelioma) entering phase I 💰 A recent $100m series E funding round

Evo 2 is a colossal 40-billion-parameter AI that’s reshaping our grasp of the genome. Powered by NVIDIA and the Arc Institute , it’s been trained on nine trillion nucleotides to pinpoint harmful mutations, model evolutionary pathways, and even generate entire synthetic genomes.

🚨 The world’s first legally authorized autonomous AI for detecting skin cancer 🚨 Skin Analytics' DERM (Deep Ensemble for the Recognition of Malignancy) has received a class III certification, meaning it can now make independent clinical decisions. The system boasts a 99.8%